Trial site
Premier Clinical Research Institute Inc
- 5running trials
- 8closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease6 trials
- Depression3 trials
- Mild cognitive impairment3 trials
- Schizophrenia2 trials
- Bipolar disorder1 trial
- Lewy body dementia1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 2/32 trials
- Status
- Completed7 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- ACADIA Pharmaceuticals Inc.3 trials
- Novo Nordisk A/S2 trials
- Syndeio Biosciences, Inc2 trials
- Annovis Bio Inc.1 trial
- Cognito Therapeutics, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Enrolling by invitation
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Depression2 recruiting
- Lewy body dementia1 recruiting
Closed trials
Completed
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Completed
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Completed
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Terminated
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: ClinicalTrials.govUpdated 12 Nov 2026